Cancer

Plexxikon Expands Management Team and Board of Directors

Published in Biotech Law Weekly, July 6th, 2007

Plexxikon Inc. announced Gary C. Visor, Ph.D. was named vice president, pharmaceutics, a new position responsible for managing pharmaceutical drug substance scale-up, manufacturing and dosage design and development, required for the company's development programs. In addition, David H. MacCallum has been appointed to Plexxikon's board of directors.

Appointment of Gary C. Visor, Vice President, Pharmaceutics

"Gary brings to Plexxikon a wealth of pharmaceutical manufacturing and operations experience which will be invaluable as we expand our clinical stage pipeline and the need for kilogram quantities of clinical-grade drug substance increases to...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Law Weekly

Source: Biotech Law Weekly (2007-07-06)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry